ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients.
van Dieren
J M
JM
van Vuuren
A J
AJ
Kusters
J G
JG
Nieuwenhuis
E E S
EE
Kuipers
E J
EJ
van der Woude
C J
CJ
D001379:Azathioprine / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008780:Methyltransferases / Q000235:genetics; D011110:Polymorphism, Genetic; D011755:Pyrophosphatases / Q000235:genetics*; D000097630:Inosine Triphosphatase
D001379:Azathioprine; D007166:Immunosuppressive Agents; D008780:Methyltransferases; D011755:Pyrophosphatases; D000097630:Inosine Triphosphatase; C022745:thiopurine methyltransferase